戻る Agenda
Brave New World: Early Clinical Trials in a Pandemic
Session Chair(s)
Anita Nelsen
Executive Vice President, Translational Medicine
Parexel, United States
This session will discuss the impact on early clinical research and development under COVID-19 and measures that were put in place to protect healthy volunteers and staff.
Learning Objective : Discuss early clinical research and development under COVID-19 pandemic conditions; Identify safety measures and operational set-up for volunteers and staff, consider how next-generation early trials may operate as a result of changes introduced through this disruption.
Speaker(s)
SARS-CoV-2 Testing, Operational Challenges, and Subject Safety Considerations Under COVID-19 Pandemic Conditions: A New Era
Sandra Stark, PhD, MSc
Parexel International, Germany
Head Early Phase Clinical Unit Berlin
Early Clinical Trials in a Pandemic: A Big Pharma Story
Jessie Gu, PhD
Novartis Institutes for BioMedical Research (NIBR), United States
Executive Director, Global Head, Ph1 Clinical Pharmacology